Editorial: Ying and Yang Members of the Tumor Necrosis Factor Superfamily: Friends or Foes in Immune-Mediated Diseases and Cancer
Front Immunol
.
2017 Nov 23:8:1584.
doi: 10.3389/fimmu.2017.01584.
eCollection 2017.
Authors
Adebola Giwa
1
2
,
Rizwan Ahmed
1
,
Thomas Donner
3
,
Hideo Yagita
4
,
Abdel Rahim A Hamad
1
3
Affiliations
1
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
2
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
3
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
4
Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.
PMID:
29218044
PMCID:
PMC5703765
DOI:
10.3389/fimmu.2017.01584
No abstract available
Keywords:
CD95L; Fas pathway; FasL; tumor necrosis factor; type 1 diabetes.
Publication types
Editorial
Grants and funding
R01 AI099027/AI/NIAID NIH HHS/United States
T32 HD044355/HD/NICHD NIH HHS/United States